Thermo Fisher Scientific to Accelerate Life Science Breakthroughs with OpenAI
"AI is shaping the future of science"
Advertisement
Thermo Fisher Scientific Inc. announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines to patients faster and more cost effectively.
Working with OpenAI, Thermo Fisher is focusing on accelerating scientific innovation, enhancing productivity and reducing complexity. As part of this collaboration, Thermo Fisher is embedding Open AI APIs (Application Programming Interfaces) into critical areas of its business - ranging from product development, service delivery, customer engagement and operational efficiency.
The collaboration will:
- Deploy OpenAI advanced capabilities to one of the highest impact initial focus areas - Thermo Fisher’s industry leading PPD ™ clinical research business - to significantly improve the cycle time of clinical trials and accelerate the time to bring new medicines to market, creating meaningful value for the industry.
- Leverage OpenAI capabilities and Thermo Fisher’s expertise, to more quickly help identify therapies that are unlikely to succeed, which will enable customers to redirect investment and resources toward more promising opportunities.
- Integrate AI into Thermo Fisher’s Accelerator ™ Drug Development solution, an end-to-end approach spanning early development, Phase I–III clinical research, clinical manufacturing and supply and commercialization. This solution is designed to deliver greater speed, simplicity and scalability for customers.
- Launch frontier AI to Thermo Fisher colleagues, with ChatGPT Enterprise, making it easier to build confidence and fluency with these powerful tools.
“AI is shaping the future of science. And when combined with our Mission to enable our customers to make the world healthier, cleaner and safer, it is a powerful catalyst to accelerate scientific advancement,” said Marc Casper, Chairman, President and Chief Executive Officer, Thermo Fisher Scientific. “With OpenAI, we’re further embedding AI across our operations, products and services. Together, we’re building an ecosystem that accelerates scientific breakthroughs and delivers impact for customers, patients and society.”
“Thermo Fisher plays a massive role in advancing science, and together we have an opportunity to accelerate how medicine can reach more people,” said Brad Lightcap, chief operating officer at OpenAI. “With OpenAI directly powering Thermo Fisher workflows, frontier AI can help cut through complexity, speed up breakthroughs, and bring real impact to patients' lives."
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
'Good' prion-like proteins boost immune response, UT Southwestern scientists report
Antibody discovered that blocks almost all known HIV variants in neutralization assays - The discovery potentially opens up new perspectives for the prevention and treatment of HIV infections
New method for measuring luminescence lifetime offers breakthrough in scientific imaging - Accelerating the pace of discovery in science and industry
Decreasing biodiversity may promote spread of viruses - New insight into the dynamics of infectious disease
Mysthera Therapeutics Launches to Develop First-in-Class Autoimmune Disease Therapies - Seed Capital from Forty51 Ventures to Advance Pipeline of Pan-PIM Kinase Inhibitors
3D-printed pills with desired drug release – a step upwards in medication - Funny looking pills are not a design gimmick, they can release medication in a desired time regime!
Coronavirus SARS-CoV-2 spreads more indoors at low humidity - Indian-German research team recommends at least 40 percent humidity in public buildings
Chemische Fabrik Dr. Weigert GmbH & Co. KG - Hamburg, Germany
KNAUER now officially a place of the future
Microscopy: Overcoming the traditional resolution limit for the fast co-tracking of molecules - Researchers have developed an innovative method to simultaneously track rapid dynamic processes of multiple molecules at the molecular scale
Molecular simulations confirm role of functional rotation in multidrug resistance